388 related articles for article (PubMed ID: 28633038)
41. Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study.
Kim JW; Kim SW; Tada K; Fukuda T; Lee JH; Lee JJ; Kwon JH; Bang SM; Kim I; Yoon SS; Lee JS; Park S
Ann Hematol; 2014 Aug; 93(8):1345-51. PubMed ID: 24633661
[TBL] [Abstract][Full Text] [Related]
42. Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
Ingram W; Devereux S; Das-Gupta EP; Russell NH; Haynes AP; Byrne JL; Shaw BE; McMillan A; Gonzalez J; Ho A; Mufti GJ; Pagliuca A
Br J Haematol; 2008 Apr; 141(2):235-43. PubMed ID: 18318762
[TBL] [Abstract][Full Text] [Related]
43. Hematopoietic cell transplantation for B-cell lymphoma: an update.
Ayala E
Cancer Control; 2012 Jul; 19(3):175-86. PubMed ID: 22710893
[TBL] [Abstract][Full Text] [Related]
44. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
Laport GG
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
[TBL] [Abstract][Full Text] [Related]
45. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO
J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164
[TBL] [Abstract][Full Text] [Related]
46. Current controversies in follicular lymphoma.
Aurora V; Winter JN
Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
[TBL] [Abstract][Full Text] [Related]
47. Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience.
Mohyuddin GR; Clark AE; Roller J; Shune L; Lin T; Dunavin N; Dias A; Ganguly S; Abhyankar S; McGuirk J; Singh A
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):135-141. PubMed ID: 29278676
[TBL] [Abstract][Full Text] [Related]
48. Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT.
Kanate AS; Kumar A; Dreger P; Dreyling M; Le Gouill S; Corradini P; Bredeson C; Fenske TS; Smith SM; Sureda A; Moskowitz A; Friedberg JW; Inwards DJ; Herrera AF; Kharfan-Dabaja MA; Reddy N; Montoto S; Robinson SP; Abutalib SA; Gisselbrecht C; Vose J; Gopal A; Shadman M; Perales MA; Carpenter P; Savani BN; Hamadani M
JAMA Oncol; 2019 May; 5(5):715-722. PubMed ID: 30816957
[TBL] [Abstract][Full Text] [Related]
49. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
[TBL] [Abstract][Full Text] [Related]
50. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
Bento L; Gutiérrez A; Novelli S; Montoro J; Piñana JL; López-Corral L; Cabrero M; Martín-Sancho A; Gutiérrez-García G; Ortiz-Moscovich M; Bastos-Oreiro M; Dorado N; Pérez A; Hernani R; Ferrà C; Parody R; García-Cadenas I; Herrera P; Rodríguez G; Rodríguez N; Martín C; Yáñez L; Zanabili J; Varela MR; López-Godino O; Heras I; Español I; Martínez C; Pérez-Simón JA; Solano C; Sureda A; Sierra J; Sampol A; Caballero D;
Bone Marrow Transplant; 2021 Aug; 56(8):1919-1928. PubMed ID: 33767400
[TBL] [Abstract][Full Text] [Related]
51. Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma.
Thomson KJ; Morris EC; Bloor A; Cook G; Milligan D; Parker A; Clark F; Yung L; Linch DC; Chakraverty R; Peggs KS; Mackinnon S
J Clin Oncol; 2009 Jan; 27(3):426-32. PubMed ID: 19064981
[TBL] [Abstract][Full Text] [Related]
52. Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas.
Epperla N; Fenske TS; Hari PN; Hamadani M
World J Transplant; 2015 Sep; 5(3):81-8. PubMed ID: 26421260
[TBL] [Abstract][Full Text] [Related]
53. Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma.
Kanate AS; Kharfan-Dabaja MA; Hamadani M
Bone Marrow Res; 2012; 2012():897215. PubMed ID: 23097707
[TBL] [Abstract][Full Text] [Related]
54. Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.
William BM; Wang T; Haagenson MD; Fleischhauer K; Verneris M; Hsu KC; de Lima MJ; Fernandez-Viña M; Spellman SR; Lee SJ; Hill BT
Biol Blood Marrow Transplant; 2018 Apr; 24(4):827-831. PubMed ID: 29155319
[TBL] [Abstract][Full Text] [Related]
55. [Allogeneic transplantation in malignant lymphoma].
Stötzer OJ; Schleuning M; Ledderose G; Hiddemann W; Kolb HJ
Dtsch Med Wochenschr; 2001 Sep; 126(39):1062-9. PubMed ID: 11602913
[TBL] [Abstract][Full Text] [Related]
56. Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.
Khaddour K; Musiek A; Cornelius LA; Dehdashti F; Westervelt P; Fields R; Ansstas G
J Immunother Cancer; 2019 Dec; 7(1):338. PubMed ID: 31801591
[TBL] [Abstract][Full Text] [Related]
57. Hematopoietic cell transplantation in non-Hodgkin's lymphoma.
Steingass SK
Semin Oncol Nurs; 2006 May; 22(2):107-16. PubMed ID: 16720233
[TBL] [Abstract][Full Text] [Related]
58. The curability of follicular lymphoma.
Lunning M; Armitage JO
Transfus Apher Sci; 2007 Aug; 37(1):31-5. PubMed ID: 17936072
[TBL] [Abstract][Full Text] [Related]
59. Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.
Picleanu AM; Novelli S; Monter A; Garcia-Cadenas I; Caballero AC; Martino R; Esquirol A; Briones J; Sierra J
Ann Hematol; 2017 May; 96(5):787-796. PubMed ID: 28168350
[TBL] [Abstract][Full Text] [Related]
60. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]